Your browser doesn't support javascript.
loading
Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy.
Warkentin, Alexander A; Lopez, Michael S; Lasater, Elisabeth A; Lin, Kimberly; He, Bai-Liang; Leung, Anskar Yh; Smith, Catherine C; Shah, Neil P; Shokat, Kevan M.
Affiliation
  • Warkentin AA; Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States.
  • Lopez MS; Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States.
  • Lasater EA; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, United States.
  • Lin K; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, United States.
  • He BL; Division of Haematology, Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
  • Leung AY; Division of Haematology, Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
  • Smith CC; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, United States.
  • Shah NP; Division of Hematology and Oncology, University of California, San Francisco, San Francisco, United States.
  • Shokat KM; Department of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States.
Elife ; 32014 Dec 22.
Article de En | MEDLINE | ID: mdl-25531068
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies de la moelle osseuse / Leucémie aigüe myéloïde / Tyrosine kinase-3 de type fms / Antinéoplasiques Limites: Animals / Humans Langue: En Journal: Elife Année: 2014 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies de la moelle osseuse / Leucémie aigüe myéloïde / Tyrosine kinase-3 de type fms / Antinéoplasiques Limites: Animals / Humans Langue: En Journal: Elife Année: 2014 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni